COMMUNIQUÉS West-GlobeNewswire
-
Correction: Choosing a Shaker Bottle for Thick Pre-Workout Powders: What Actually Prevents Clumping
23/07/2026 -
Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Advanced Parkinson’s Disease
23/07/2026 -
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
23/07/2026 -
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
23/07/2026 -
Aveanna Announces Second Quarter 2026 Earnings Release Date and Conference Call
23/07/2026 -
AAVantgarde Announces Participation of Founder and CSO, Prof. Alberto Auricchio at the 32nd Annual Meeting of the Japanese Society for Gene and Cell Therapy
23/07/2026 -
Sotera Health Announces Second-Quarter 2026 Earnings Release Date
23/07/2026 -
Tilray Brands Launches ZONNA, Introducing New THC Pouches for Cannabis Consumers
23/07/2026 -
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026 -
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
23/07/2026 -
ZoomRx Launches Signal-IQ: Competitive Field Intelligence, Delivering Real-Time NPI-Level Visibility into Competitor Sales Force Activity for Pharma Commercial Teams
23/07/2026 -
Commure Wins Two Stevie® Awards for Technology Excellence, Including Gold for Company of the Year in Healthcare Technology
23/07/2026 -
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
23/07/2026 -
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026 -
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026 -
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm
23/07/2026 -
CLINUVEL implements strategic reorganisation to refocus on U.S. markets
23/07/2026 -
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
23/07/2026 -
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
Pages